Published in Clin Endocrinol (Oxf) on October 01, 1993
Growth hormone replacement in adults: what dose? Clin Endocrinol (Oxf) (1993) 0.75
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia (1983) 4.48
Insulin resistance in microvascular angina (syndrome X) Lancet (1993) 3.02
Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab (2001) 2.98
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Prenatal and postnatal prevalence of Turner's syndrome: a registry study. BMJ (1996) 2.65
Inhibition of insulin secretion by somatostatin. Lancet (1973) 2.58
Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med (2011) 2.30
Morbidity in Turner syndrome. J Clin Epidemiol (1998) 2.23
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89
Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration. Diabetologia (1980) 1.71
Cubilin is an albumin binding protein important for renal tubular albumin reabsorption. J Clin Invest (2000) 1.66
Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet (1989) 1.63
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes (2001) 1.59
Diabetes, diabetic angiopathy, and growth hormone. Lancet (1970) 1.56
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study. Diabet Med (2005) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
Dose-response effects of free fatty acids on amino acid metabolism and ureagenesis. Acta Physiol (Oxf) (2007) 1.52
Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature (1968) 1.49
Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia (1981) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
The metabolic effects of quinine in children with severe and complicated Plasmodium falciparum malaria in Dar es Salaam. Trans R Soc Trop Med Hyg (1992) 1.44
Circadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia (1992) 1.42
Muscle mass and function in thyrotoxic patients before and during medical treatment. Clin Endocrinol (Oxf) (1999) 1.42
Effects of heparin on renal morphology and albuminuria in experimental diabetes. Am J Physiol (1996) 1.40
Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2011) 1.40
Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.37
Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol (1997) 1.31
Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab (2005) 1.31
Fast glycosylation of haemoglobin. Lancet (1979) 1.28
Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev (1999) 1.26
Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia (1981) 1.24
Synthesis of 125I monolabelled 3, 5, 3'-triiodothyronine and thyroxine of maximum specific activity for radioimmunoassay. Scand J Clin Lab Invest (1973) 1.22
Free insulin-like growth factors in human obesity. Metabolism (1995) 1.20
Letter: Diagonal ear-lobe crease in coronary heart disease. N Engl J Med (1975) 1.18
Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab (2009) 1.17
Reduced sweating in adults with growth hormone deficiency. Lancet (1989) 1.16
Vibratory perception during ischaemia in uraemic patients and in subjects with mild carbohydrate intolerance. J Neurol Neurosurg Psychiatry (1969) 1.16
Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol (1990) 1.15
The relationship between endogenous serum insulin concentration and glucose uptake in the forearm muscles of nondiabetics. J Clin Invest (1968) 1.14
Renal function in streptozotocin-diabetic rats. Diabetologia (1981) 1.13
Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol Endocrinol Metab (2002) 1.12
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism (1994) 1.12
Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes (1983) 1.12
Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes. Diabetes (1988) 1.11
Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment. Acta Paediatr (1997) 1.10
Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab (2000) 1.10
Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab (2000) 1.10
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul (1995) 1.08
Lipid metabolites and nitrogen balance after abdominal surgery in man. Br J Surg (1979) 1.08
Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia (1984) 1.07
Plasma disappearance rate of injected human insulin in juvenile diabetic, maturity-onset diabetic and nondiabetic subjects. Diabetes (1969) 1.07
Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care (1998) 1.06
Detection of growth hormone abuse in sport. Growth Horm IGF Res (2007) 1.05
Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int (1982) 1.05
Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes (2001) 1.05
Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.05
Glucose monitoring by microdialysis: performance in a multicentre study. Diabet Med (2009) 1.04
Fast glycosylation of hemoglobin. Lancet (1979) 1.03
GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab (2001) 1.03
Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. J Clin Endocrinol Metab (2011) 1.03
Growth hormone administration by means of an injection pen. Pharmacol Toxicol (1989) 1.03
Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment Pharmacol Ther (2009) 1.02
Synthesis of glycosylated haemoglobin in vivo. Diabetologia (1981) 1.02
The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) (1985) 1.02
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract (2011) 1.01
Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. Am J Physiol (1999) 1.01
Characterisation of somatostatin release from the pancreas: the role of calcium and acetylcholine. Diabetologia (1979) 1.01
Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults. J Clin Endocrinol Metab (2001) 1.00
Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol (1998) 1.00
Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99
Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. J Clin Endocrinol Metab (2008) 0.99
Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab (2000) 0.99
The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia (1981) 0.99
Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int (1986) 0.99
Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study. Eur J Endocrinol (2008) 0.99
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism (1996) 0.99
Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism (2000) 0.99
Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women. J Appl Physiol (1985) (2008) 0.99
Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clin Endocrinol (Oxf) (1996) 0.99
Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans. J Clin Endocrinol Metab (2007) 0.99
Some actions of growth hormone release inhibiting factor. Br Med J (1973) 0.98
Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett (1994) 0.97
Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. J Clin Endocrinol Metab (2003) 0.97